Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSE: Early Neuromuscular Blockade in ARDS
NCT02509078Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisatracurium in acute respiratory distress syndrome (ARDS), sponsored by Massachusetts General Hospital. Started Jan 2016; status: completed.
02
Drugs
cisatracurium
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT02509078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02509078.